Alps Advisors Inc Corcept Therapeutics Inc Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Alps Advisors Inc holds 88,989 shares of CORT stock, worth $4.57 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

88,989

Previous 95,766 7.08%

Holding current value

$4.57 Million

Previous $3.11 Million 32.3%

% of portfolio

0.03%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$29.51 - $46.26 $199,989 - $313,504	-6,777 Reduced 7.08%	88,989 $4.12 Million
Q2 2024 Aug 13, 2024	BUY	$22.21 - $34.48 $180,389 - $280,046	8,122 Added 9.27%	95,766 $3.11 Million
Q1 2024 May 14, 2024	BUY	$21.1 - $27.46 $322,492 - $419,698	15,284 Added 21.12%	87,644 $2.21 Million
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $83,022 - $109,983	-3,345 Reduced 4.42%	72,360 $2.35 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $22,870 - $35,185	1,041 Added 1.39%	75,705 $2.06 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $76,669 - $89,936	3,576 Added 5.03%	74,664 $1.66 Million
Q1 2023 May 10, 2023	SELL	$19.2 - $24.47 $36,211 - $46,150	-1,886 Reduced 2.58%	71,088 $1.54 Million
Q4 2022 Feb 14, 2023	BUY	$19.95 - $29.96 $1.46 Million - $2.19 Million	72,974 New	72,974 $1.48 Million
Q2 2022 Aug 11, 2022	SELL	$17.33 - $25.3 $2,582 - $3,769	-149 Reduced 1.02%	14,486 $344,000
Q1 2022 May 16, 2022	BUY	$16.53 - $25.21 $241,916 - $368,948	14,635 New	14,635 $330,000
Q1 2021 May 07, 2021	SELL	$23.49 - $30.56 $344,339 - $447,979	-14,659 Closed	0 $0
Q4 2020 Feb 03, 2021	SELL	$16.78 - $27.3 $5,017 - $8,162	-299 Reduced 2.0%	14,659 $383,000
Q3 2020 Nov 04, 2020	BUY	$12.46 - $19.98 $186,376 - $298,860	14,958 New	14,958 $260,000
Q1 2020 May 06, 2020	SELL	$10.11 - $14.04 $257,127 - $357,079	-25,433 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$12.06 - $16.96 $13,591 - $19,113	-1,127 Reduced 4.24%	25,433 $308,000
Q3 2019 Nov 04, 2019	SELL	$10.41 - $14.66 $42,025 - $59,182	-4,037 Reduced 13.19%	26,560 $375,000
Q2 2019 Aug 07, 2019	SELL	$9.78 - $12.76 $15,784 - $20,594	-1,614 Reduced 5.01%	30,597 $341,000
Q1 2019 May 01, 2019	SELL	$10.03 - $15.71 $2,306 - $3,613	-230 Reduced 0.71%	32,211 $378,000
Q4 2018 Feb 04, 2019	SELL	$11.29 - $17.19 $14,767 - $22,484	-1,308 Reduced 3.88%	32,441 $433,000
Q3 2018 Oct 25, 2018	BUY	$12.27 - $15.65 $99,865 - $127,375	8,139 Added 31.78%	33,749 $473,000
Q2 2018 Aug 02, 2018	SELL	$15.3 - $19.69 $9,210 - $11,853	-602 Reduced 2.3%	25,610 $403,000
Q2 2018 Jul 25, 2018	SELL	$15.3 - $19.69 $9,210 - $11,853	-602 Reduced 2.25%	26,212 $473,000
Q1 2018 May 01, 2018	BUY	$14.59 - $25.5 $8,783 - $15,351	602 Added 2.3%	26,814 $441,000
Q3 2017 Nov 03, 2017	BUY	$12.3 - $19.3 $322,407 - $505,891	26,212	26,212 $506,000

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.51B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Corcept Therapeutics Inc Transaction History